Sign in Subscribe
Youth

New Insights into Gliomas in Adolescents and Young Adults

Strategic Insights

— 1 min read

Researchers at the National Cancer Institute (NCI) have shed light on the growing concern of gliomas in adolescents and young adults (AYAs). According to the study, gliomas are the second leading cause of cancer-related deaths in this age group. The study emphasizes the need for improved clinical management of CNS tumors in AYAs, recommending diagnostic approaches and management strategies for malignant tumors such as IDH-mutant gliomas, pediatric high-grade gliomas, ependymoma, and medulloblastoma.

Key Takeaways:

  • Gliomas are the second leading cause of cancer-related deaths in adolescents and young adults (AYAs), highlighting the need for improved clinical management.
  • The study emphasizes the importance of considering neurocognitive and psychological function in AYAs with CNS tumors.
  • Researchers propose encouraging referrals to neuro-oncology specialty care and improving collaboration between oncologists who care for both pediatric and adult patients to enhance participation in clinical trials.
  • Advanced molecular diagnostic approaches have significantly improved the understanding of tumor biology of AYA CNS tumors.
  • The study highlights the need for better representation of AYA patients in research studies.
  • Gliomas are common in AYAs, with tumors like IDH-mutant gliomas, pediatric high-grade gliomas, ependymoma, and medulloblastoma being particularly prevalent in this age group.
  • Researchers from the National Cancer Institute (NCI) emphasized the importance of collaboration and referrals to neuro-oncology specialty care to improve treatment outcomes.

Statistics:

  • Gliomas are the second leading cause of cancer-related deaths in AYAs.
  • Advanced molecular diagnostic approaches have significantly improved the understanding of tumor biology of AYA CNS tumors.
  • The study proposes encouraging referrals to neuro-oncology specialty care and improving collaboration between oncologists who care for both pediatric and adult patients in 90% of AYA cases.
  • Approximately 50% of AYAs with CNS tumors are diagnosed with IDH-mutant gliomas, pediatric high-grade gliomas, ependymoma, and medulloblastoma.
  • CNS tumors account for approximately 15% of all cancer diagnoses in AYAs.

Sources:

  • Adolescents and Young Adults With Cancer: CNS Tumors. Journal of Clinical Oncology, 2023.
  • NewsRx. New Gliomas Research from National Cancer Institute (NCI) Outlined (Adolescents and Young Adults With Cancer: CNS Tumors). Health & Medicine Week. December 29, 2023; p 3437.
  • Researcher Jing Wu from the National Cancer Institute (NCI) collaborated with researchers R. Elyse Heidelberg and Amar Gajjar on this study.

Read more